Finally, delivery of the Thera-cHANPs is reached by using angiopep-2 able to trigger transcytosis and traverse the BBB by recognizing low-density lipoprotein related protein-1 (LRP-1) expressed on the brain capillary endothelial cells and overexpressed on glioma cells. The gene discussed is LRP1; the disease is central nervous system cancer.